Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
AngioDynamics revenue
AngioDynamics's revenue is $303.9 million.
What is AngioDynamics's revenue?
- AngioDynamics's revenue growth from 2004 to 2024 is 519.54%.
- AngioDynamics has 1,050 employees, and the revenue per employee ratio is $289,441.
- AngioDynamics's peak quarterly revenue was $94.1M in 2014(q4).
- AngioDynamics peak revenue was $356.5M in 2015.
- AngioDynamics annual revenue for 2023 was 338.8M, 7.13% growth from 2022.
- AngioDynamics annual revenue for 2024 was 303.9M, -10.28% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
AngioDynamics historical revenue
AngioDynamics's peak revenue was $356.5M in 2015. The peak quarterly revenue was $94.1M in 2014(q4).
AngioDynamics's revenue increased from $49.1m in 2004 to $303.9M currently. That's a 519.54% change in annual revenue.
AngioDynamics annual revenue
AngioDynamics annual revenue over time
| Fiscal year / year | AngioDynamics revenue |
|---|---|
| 2009 | $195.1M |
| 2010 | $216.0M |
| 2011 | $215.8M |
| 2012 | $221.9M |
| 2013 | $341.9M |
| 2014 | $354.4M |
| 2015 | $356.5M |
| 2016 | $353.9M |
| 2017 | $269.8M |
| 2018 | $261.7M |
| 2019 | $270.6M |
| 2020 | $264.2M |
| 2021 | $291.0M |
| 2022 | $316.2M |
| 2023 | $338.8M |
| 2024 | $303.9M |
How accurately did AngioDynamics' revenue projections match actual performance?
AngioDynamics annual growth
AngioDynamics saw the greatest revenue growth in 2013, when revenue increased by 54.07%.
AngioDynamics had the lowest revenue growth in 2017, when revenue changed by -23.77%.
AngioDynamics annual growth rate over time
| Year | AngioDynamics growth |
|---|---|
| 2009 | 17%↑ |
| 2010 | 11%↑ |
| 2011 | -0%↓ |
| 2012 | 3%↑ |
| 2013 | 54%↑ |
| 2014 | 4%↑ |
| 2015 | 1%↑ |
| 2016 | -1%↓ |
| 2017 | -24%↓ |
| 2018 | -3%↓ |
| 2019 | 3%↑ |
| 2020 | -2%↓ |
| 2021 | 10%↑ |
| 2022 | 9%↑ |
| 2023 | 7%↑ |
| 2024 | -10%↓ |
AngioDynamics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
AngioDynamics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $44.3M | $48.5M | $49.4M | $52.8M |
| 2010 | $50.1M | $53.5M | $52.2M | $60.3M |
| 2011 | $51.5M | $53.4M | $54.6M | $56.2M |
| 2012 | $54.4M | $58.1M | $51.6M | $57.8M |
| 2013 | $83.4M | $87.0M | $81.6M | $89.9M |
| 2014 | $83.6M | $88.6M | $88.2M | $94.1M |
| 2015 | $87.3M | $92.1M | $86.6M | $90.5M |
| 2016 | $83.8M | $89.3M | $87.4M | $93.4M |
| 2017 | $88.1M | $89.0M | $85.6M | $7.1M |
| 2018 | $85.4M | $86.7M | $83.9M | $5.7M |
| 2019 | $63.9M | $70.0M | $65.5M | $71.2M |
| 2020 | $66.0M | $70.0M | $69.8M | $58.3M |
| 2021 | $70.2M | $72.8M | $71.2M | $76.8M |
| 2022 | $77.0M | $78.3M | $74.0M | $87.0M |
| 2023 | $81.5M | $85.4M | $80.7M | $91.1M |
| 2024 | $78.7M | $79.1M | $75.2M | $71.0M |
| 2025 | $67.5M | $72.8M | $72.0M | - |
AngioDynamics jobs nearby
Do you work at AngioDynamics?
Did AngioDynamics meet its revenue projections?
AngioDynamics financial information
| CEO | James Christopher Clemmer |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 1,050 |
| Date Founded | 1988 |
| Number of Locations | 4 |
| Revenue | $303.9M |
| Net Income | -$52,442,000 |
| Gross Proft | $154.7M (2024) |
| EBITDA | ($180.2M) (2024) |
| PE Ratio | -4.18 |
| Tax Rate | 0.0% |
| Market Capitalization | $770.3M |
| Total Assets | $532,637,000 |
| Ticker | ANGO |
AngioDynamics jobs you might like
AngioDynamics competitors
AngioDynamics's top competitor, Medtronic, earned an annual revenue of $17.0B.
AngioDynamics's smallest competitor is Uckele Equine with revenue of $2.1M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| NeuroPace | $46,429 | $79.9M | 152 | 13 |
| Medtronic | $73,671 | $17.0B | 104,950 | 2,255 |
| Medical Components | $44,873 | $18.1M | 50 | - |
| Edwards Lifesciences | $112,516 | $5.4B | 14,000 | 597 |
| Cook Group | $47,314 | $2.0B | 12,000 | 136 |
| Boston Scientific | $60,291 | $16.7B | 36,000 | 832 |
| Arizona Nutritional Supplements | $47,115 | $320.0M | 750 | 6 |
| Clondalkin Pharma & Healthcare Inc | $43,750 | $79.0M | 850 | - |
| Merit Medical Systems | $40,964 | $1.3B | 6,446 | 43 |
| ReVision Optics | $69,217 | $3.2M | 125 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
AngioDynamics highest paying jobs
Zippia gives an in-depth look into the details of AngioDynamics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about AngioDynamics. The employee data is based on information from people who have self-reported their past or current employments at AngioDynamics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by AngioDynamics. The data presented on this page does not represent the view of AngioDynamics and its employees or that of Zippia.
AngioDynamics may also be known as or be related to ANGIODYNAMICS INC, AngioDynamics, AngioDynamics Inc, AngioDynamics, Inc., Angiodynamics and Angiodynamics, Inc.